JP2023520330A5 - - Google Patents
Info
- Publication number
- JP2023520330A5 JP2023520330A5 JP2022557840A JP2022557840A JP2023520330A5 JP 2023520330 A5 JP2023520330 A5 JP 2023520330A5 JP 2022557840 A JP2022557840 A JP 2022557840A JP 2022557840 A JP2022557840 A JP 2022557840A JP 2023520330 A5 JP2023520330 A5 JP 2023520330A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- heteroaryl
- heterocyclyl
- inhibitor
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994259P | 2020-03-24 | 2020-03-24 | |
| US62/994,259 | 2020-03-24 | ||
| US202163139394P | 2021-01-20 | 2021-01-20 | |
| US63/139,394 | 2021-01-20 | ||
| PCT/US2021/023981 WO2021195279A2 (en) | 2020-03-24 | 2021-03-24 | Small molecule inhibitors of oncogenic chd1l with preclinical activity against colorectal cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520330A JP2023520330A (ja) | 2023-05-17 |
| JP2023520330A5 true JP2023520330A5 (https=) | 2024-04-04 |
Family
ID=77892666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022557840A Pending JP2023520330A (ja) | 2020-03-24 | 2021-03-24 | 結腸直腸がんに対する前臨床活性を有する発がん性ｃｈｄ１ｌの低分子阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4127209A4 (https=) |
| JP (1) | JP2023520330A (https=) |
| CN (1) | CN115667553A (https=) |
| AU (1) | AU2021244209A1 (https=) |
| CA (1) | CA3172987A1 (https=) |
| WO (1) | WO2021195279A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3222727A1 (en) * | 2021-06-17 | 2022-12-22 | The Regents Of The University Of California | E3 ligase inhibitors and methods of use thereof |
| WO2023055763A2 (en) * | 2021-09-30 | 2023-04-06 | The Regents Of The University Of Colorado, A Body Corporate | Small molecule inhibitors of oncogenic chd1l with preclinical activity against colorectral cancer |
| CN114457007B (zh) * | 2022-02-28 | 2024-05-28 | 合肥燃音生物科技有限公司 | 一种基于微孔板的均一的单类器官模型及其制备方法 |
| CA3250274A1 (en) * | 2022-05-02 | 2023-11-09 | Eisbach Bio Gmbh | USE OF ALC1 INHIBITORS AND SYNERGY WITH PARPI |
| CN115290774B (zh) * | 2022-07-21 | 2023-07-21 | 重庆医科大学 | 尿苷二磷酸葡萄糖醛酸在制备用于检测肝癌试剂中的应用 |
| WO2024211314A2 (en) * | 2023-04-03 | 2024-10-10 | The Regents Of The University Of Colorado, A Body Corporate | Inhibitors of chd1l and uses thereof |
| WO2025088087A1 (en) | 2023-10-25 | 2025-05-01 | Eisbach Bio Gmbh | A pyrido-thieno-pyrimidin derivative as alc1 inhibitor for use in the treatment of homologous recombination deficiency (hrd) cancers |
| AU2024366320A1 (en) * | 2023-10-25 | 2026-04-16 | Eisbach Bio Gmbh | Alc1 inhibitors for use in treating cancer by potentiating the effects of several classes of approved cancer drugs |
| WO2025093706A1 (en) * | 2023-10-31 | 2025-05-08 | Eisbach Bio Gmbh | Alc1 inhibitors alc1i-1 and alc1i-2 for use in treating pancreatic cancer by potentiating the effect of irinotecan |
| WO2025129032A1 (en) * | 2023-12-15 | 2025-06-19 | The Regents Of The University Of Colorado, A Body Corporate | Chd1l inhibitors for treating cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060211603A1 (en) * | 2004-08-18 | 2006-09-21 | Vicuron Pharmaceuticals Inc. | Ramoplanin derivatives possessing antibacterial activity |
| CN102792160B (zh) * | 2010-01-08 | 2015-08-19 | 新加坡科技研究局 | 用于治疗癌症的方法和组合物 |
| US20140243403A1 (en) * | 2011-06-03 | 2014-08-28 | The General Hospital Corporation | Treating colorectal, pancreatic, and lung cancer |
| BR112015003655A2 (pt) * | 2012-08-23 | 2017-07-04 | Virostatics Srl | composto; uso de um composto; e composição farmacêutica |
| US20160138114A1 (en) * | 2013-06-19 | 2016-05-19 | The Regents Of The University Of California | Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer |
| CN108976172B (zh) * | 2017-05-31 | 2021-12-07 | 华东师范大学 | 一类4-嘧啶二胺类小分子有机化合物及其衍生物及其应用 |
| CN109761909B (zh) * | 2019-01-25 | 2022-08-26 | 中国药科大学 | N-(4-(嘧啶-4-氨基)苯基)磺酰胺类抑制剂或其可药用的盐、其制备方法及用途 |
-
2021
- 2021-03-24 CN CN202180037594.1A patent/CN115667553A/zh active Pending
- 2021-03-24 AU AU2021244209A patent/AU2021244209A1/en active Pending
- 2021-03-24 JP JP2022557840A patent/JP2023520330A/ja active Pending
- 2021-03-24 CA CA3172987A patent/CA3172987A1/en active Pending
- 2021-03-24 EP EP21775064.5A patent/EP4127209A4/en active Pending
- 2021-03-24 WO PCT/US2021/023981 patent/WO2021195279A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023520330A5 (https=) | ||
| RU2405780C2 (ru) | Химические соединения | |
| JP2022506887A5 (https=) | ||
| RU2345996C1 (ru) | Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения | |
| CY1122949T1 (el) | ΠΥΡΑΖΟΛΟ[1,5-a]ΠΥΡΑΖΙΝ-4-ΥΛΟ ΠΑΡΑΓΩΓΑ ΩΣ JAK-ΑΝΑΣΤΟΛΕΙΣ | |
| JP2009536620A5 (https=) | ||
| MX2021009763A (es) | Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos. | |
| IL275762B1 (en) | Derivatives of phenyl-so2-nh-c(=o)-phenyl-piperazine-ch2-1,2-cyclohexane-bicyclo[1.1.1]pentane and pharmaceutical compositions comprising them | |
| JP2011520832A5 (https=) | ||
| JP2011507854A5 (https=) | ||
| RU2018138828A (ru) | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами | |
| JP2021510376A5 (https=) | ||
| AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
| HUP0302891A2 (hu) | PDE4 izoenzimek inhibitoraiként alkalmazható éterszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| JP2021501756A5 (https=) | ||
| TW200611907A (en) | Fused heterocyclic compound | |
| JP2008517983A5 (https=) | ||
| HUP0401819A2 (hu) | Proteinkináz inhibitorokként alkalmazható pirazolvegyületek és ezeket tartalmazó gyógyszerkészítmények | |
| BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
| RU2014140735A (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2012508252A5 (https=) | ||
| CO6231028A2 (es) | Compuestos y composiciones como inhibidores de la proteina quinasa | |
| RU2008112691A (ru) | Азотсодержащее гетероциклическое соединение и его фармацевтическое применение | |
| AR109931A1 (es) | Compuesto inhibidor de la prostaglandina d sintasa hematopoyética (h-pgds), composición farmacéutica que lo comprende y uso del compuesto para fabricar un medicamento | |
| JP2015516000A5 (https=) |